Association of DRD2 gene variant with schizophrenia

被引:41
作者
Kukreti, R
Tripathi, S
Bhatnagar, P
Gupta, S
Chauhan, C
Kubendran, S
Reddy, YCJ
Jain, S
Brahmachari, SK
机构
[1] Nicholas Piramal India Ltd, Inst Genom & Integrat Biol, CSIR, GenoMed Lab Gene Quest Lab, Delhi 110007, India
[2] Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Bangalore 560029, Karnataka, India
关键词
schizophrenia; dopamine D2 receptor; synonymous mutation; association study;
D O I
10.1016/j.neulet.2005.08.059
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Schizophrenia is a complex multifactorial disorder for which the pathobiology still remains elusive. Dysfunction of the dopamine D2 receptor signaling has been associated with the illness, but numerous studies provide confounding results. This study investigates the association of synonymous polymorphisms (His313 and Pro319) in the dopamine D2 receptor gene with schizophrenia using a case-control approach, with 101 cases and 145 controls. Our results demonstrated that genotype distribution for the His313 polymorphism was significantly different between schizophrenia patients and control subjects (p = 0.0012), while the Pro319 polymorphism did not show any association with the disease. The results suggest that the synonymous SNP His313 in DRD2 may be associated with the illness. However, there is a need for further replication studies with larger sample sets. (C) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:68 / 71
页数:4
相关论文
共 41 条
[1]   Gene expression and molecular evolution [J].
Akashi, H .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2001, 11 (06) :660-666
[2]   STRUCTURE AND EXPRESSION OF HUMAN AND RAT D2-DOPAMINE RECEPTOR GENES [J].
ARAKI, K ;
KUWANO, R ;
MORII, K ;
HAYASHI, S ;
MINOSHIMA, S ;
SHIMIZU, N ;
KATAGIRI, T ;
USUI, H ;
KUMANISHI, T ;
TAKAHASHI, Y .
NEUROCHEMISTRY INTERNATIONAL, 1992, 21 (01) :91-98
[3]   A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia [J].
Arinami, T ;
Gao, M ;
Hamaguchi, H ;
Toru, M .
HUMAN MOLECULAR GENETICS, 1997, 6 (04) :577-582
[4]   ASSOCIATION OF DOPAMINE D2 RECEPTOR MOLECULAR VARIANT WITH SCHIZOPHRENIA [J].
ARINAMI, T ;
ITOKAWA, M ;
ENGUCHI, H ;
TAGAYA, H ;
YANO, S ;
SHIMIZU, H ;
HAMAGUCHI, H ;
TORU, M .
LANCET, 1994, 343 (8899) :703-704
[5]  
Breen G, 1999, AM J MED GENET, V88, P407, DOI 10.1002/(SICI)1096-8628(19990820)88:4<407::AID-AJMG19>3.0.CO
[6]  
2-3
[7]  
Carlini DB, 2001, GENETICS, V159, P623
[8]   Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence [J].
Carlsson, A ;
Waters, N ;
Holm-Waters, S ;
Tedroff, J ;
Nilsson, M ;
Carlsson, ML .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 :237-260
[9]   Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor [J].
Duan, JB ;
Wainwright, MS ;
Comeron, JM ;
Saitou, N ;
Sanders, AR ;
Gelernter, J ;
Gejman, PV .
HUMAN MOLECULAR GENETICS, 2003, 12 (03) :205-216
[10]   The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia [J].
Dubertret, C ;
Gouya, L ;
Hanoun, N ;
Deybach, JC ;
Adès, J ;
Hamon, M ;
Gorwood, P .
SCHIZOPHRENIA RESEARCH, 2004, 67 (01) :75-85